NDC 51662-1326-2 - 2% LIDOCAINE HCI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1326
- Requested NDC
- 51662-1326-2
- Package NDCs from labels
- 51662-1326-1, 51662-1326-2, 51662-1326-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 2% LIDOCAINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1326-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
| 51662-1326-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-90f7-f424-e053-dadaa90a57ce | 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) 50mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1326-1 | 2% LIDOCAINE HCI | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 7 | |
| 51662-1326-2 | 2% LIDOCAINE HCI | 1 mL in 1 POUCH | INJECTION, SOLUTION | 1 | 7 | |
| 51662-1326-3 | 2% LIDOCAINE HCI | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1326 | 2% LIDOCAINE HCI INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240130_78d8fb0a-bfae-6599-e053-2991aa0a2e03.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | c5cc87df-df3f-42b8-af84-5f2045d42084 | 2026-07-30 | Warnings, Adverse reactions | V13007Z41A |
| Aspercreme Lidocaine No-Mess plus Lavender | LIDOCAINE HCL | Chattem, Inc. | 3948a3d2-ce04-4703-8709-211e75c9c38d | 2026-07-29 | Warnings | V13007Z41A |
| Aspercreme Professional Cream | LIDOCAINE HCL 4% | Chattem, Inc. | ef297864-5917-4645-8ec7-f2bc49e037e8 | 2026-07-29 | Warnings | V13007Z41A |
| Xylocaine MPF | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 50aa6133-0776-4714-9821-fe8581f635ca | 2026-07-28 | Warnings, Adverse reactions | 1737757 |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | 9419ac39-9b26-4cca-a2d6-167205fede24 | 2026-07-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Patterson Dental | 6506755f-c9f7-4286-9ba7-ac5d5745f5e4 | 2026-07-28 | Warnings, Adverse reactions | V13007Z41A |
| Aspercreme Lidocaine with Rosemary and Mint | LIDOCAINE HYDROCHLORIDE | Chattem, Inc. | 9d40bfea-85d0-4943-83e9-0c16e79a011c | 2026-07-28 | Warnings | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Darby Dental Supply, LLC | 27e8fdfb-e923-4f99-aff7-8b9e50228151 | 2026-07-27 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Darby Dental Supply, LLC | e5ed4c2a-e320-48cf-a2fd-61d48481c624 | 2026-07-27 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Patterson Dental | f074c0dc-7c3f-46fd-a480-b8337a19fe5c | 2026-07-27 | Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| AEROBURN | LIDOCAINE HYDROCHLORIDE | Aero Healthcare US LLC | f8fa72db-5f7a-4158-a2b3-f8bc0e12df9f | 2026-07-24 | Warnings | V13007Z41A |
| AEROBURN | LIDOCAINE HYDROCHLORIDE | Aero Healthcare US LLC | a32cbc19-ec30-4634-b70d-664f2a2edd95 | 2026-07-24 | Warnings | V13007Z41A |
| Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | CVS Pharmacy | 49003aac-184c-ae33-e063-6294a90a29c0 | 2026-07-24 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.